BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014;218:206-217. [PMID: 24315890 DOI: 10.1016/j.jamcollsurg.2013.10.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Hornick JL. Subclassification of pleomorphic sarcomas: How and why should we care? Ann Diagn Pathol 2018;37:118-24. [PMID: 30340082 DOI: 10.1016/j.anndiagpath.2018.10.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
2 Xie C, Shen Y. Primary dedifferentiated Liposarcoma of vagina: a first case report. Diagn Pathol 2021;16:3. [PMID: 33422117 DOI: 10.1186/s13000-020-01062-3] [Reference Citation Analysis]
3 Ford S, Almond L, Gronchi A. An Update on Non-extremity Soft Tissue Sarcomas. Clinical Oncology 2017;29:516-27. [DOI: 10.1016/j.clon.2017.02.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jo VY, Demicco EG. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors. Head Neck Pathol 2022. [PMID: 35312984 DOI: 10.1007/s12105-022-01425-w] [Reference Citation Analysis]
5 Dingley B, Fiore M, Gronchi A. Personalizing surgical margins in retroperitoneal sarcomas: an update. Expert Review of Anticancer Therapy 2019;19:613-31. [DOI: 10.1080/14737140.2019.1625774] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
6 Lu J, Wood D, Ingley E, Koks S, Wong D. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma. Mol Biol Rep 2021;48:3637-47. [PMID: 33893924 DOI: 10.1007/s11033-021-06362-5] [Reference Citation Analysis]
7 Bill KL, Casadei L, Prudner BC, Iwenofu H, Strohecker AM, Pollock RE. Liposarcoma: molecular targets and therapeutic implications. Cell Mol Life Sci 2016;73:3711-8. [PMID: 27173057 DOI: 10.1007/s00018-016-2266-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
8 Bill KL, Garnett J, Meaux I, Ma X, Creighton CJ, Bolshakov S, Barriere C, Debussche L, Lazar AJ, Prudner BC, Casadei L, Braggio D, Lopez G, Zewdu A, Bid H, Lev D, Pollock RE. SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma. Clin Cancer Res 2016;22:1150-60. [PMID: 26475335 DOI: 10.1158/1078-0432.CCR-15-1522] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 7.7] [Reference Citation Analysis]
9 Spicer JL. Retroperitoneal Liposarcoma: An Unusual Presentation of a Rare Cancer. J Adv Pract Oncol 2021;12:854-62. [PMID: 35295543 DOI: 10.6004/jadpro.2021.12.8.6] [Reference Citation Analysis]
10 Willis F, Schimmack S, Uhl M, Haefner MF, Mechtersheimer G, Hinz U, Schmidt T, Debus J, Fröhling S, Schneider M. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma. Eur J Surg Oncol 2020;46:905-13. [PMID: 31892479 DOI: 10.1016/j.ejso.2019.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Nussbaum DP, Rushing CN, Lane WO, Cardona DM, Kirsch DG, Peterson BL, Blazer DG. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. The Lancet Oncology 2016;17:966-75. [DOI: 10.1016/s1470-2045(16)30050-x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 45] [Article Influence: 19.2] [Reference Citation Analysis]
12 Fairweather M, Wang J, Devlin PM, Hansen J, Baldini EH, Ready JE, Sugarbaker DJ, Bertagnolli MM, Raut CP. Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol 2015;22:1455-63. [PMID: 25341749 DOI: 10.1245/s10434-014-4171-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
13 Dehner CA, Hagemann IS, Chrisinger JSA. Retroperitoneal Dedifferentiated Liposarcoma. Am J Clin Pathol 2021;156:920-5. [PMID: 34125170 DOI: 10.1093/ajcp/aqab051] [Reference Citation Analysis]
14 Callegaro D, Miceli R, Brunelli C, Colombo C, Sanfilippo R, Radaelli S, Casali PG, Caraceni A, Gronchi A, Fiore M. Long-term morbidity after multivisceral resection for retroperitoneal sarcoma. British Journal of Surgery 2015;102:1079-87. [DOI: 10.1002/bjs.9829] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
15 Kitasaki N, Abe T, Oshita A, Kobayashi T, Yonehara S, Ohdan H, Noriyuki T, Nakahara M. Long-term survival by repeat resection for metastases from primary retroperitoneal leiomyosarcoma: A case report. Int J Surg Case Rep 2021;82:105891. [PMID: 33873081 DOI: 10.1016/j.ijscr.2021.105891] [Reference Citation Analysis]
16 Kneisl JS, Coleman MM, Raut CP. Outcomes in the management of adult soft tissue sarcomas. J Surg Oncol 2014;110:527-38. [PMID: 24965077 DOI: 10.1002/jso.23685] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
17 Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW. The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center. J Surg Oncol 2018;117:1799-805. [PMID: 29723411 DOI: 10.1002/jso.25082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Fairweather M, Gonzalez RJ, Strauss D, Raut CP. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018;117:33-41. [PMID: 29315649 DOI: 10.1002/jso.24919] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
19 Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol 2018;117:62-8. [DOI: 10.1002/jso.24929] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
20 Tan MC, Yoon SS. Surgical management of retroperitoneal and pelvic sarcomas. J Surg Oncol 2015;111:553-61. [PMID: 25482329 DOI: 10.1002/jso.23840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection. Ann Surg Oncol 2018;25:98-106. [DOI: 10.1245/s10434-017-6136-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
22 Gladdy RA, Gupta A, Catton CN. Retroperitoneal Sarcoma. Surgical Oncology Clinics of North America 2016;25:697-711. [DOI: 10.1016/j.soc.2016.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
23 Mahjoubi Z, Zakhama W, Sakly A, Njima M, Mnasser A, Binous Y. Giant recurrent liposarcoma of the retroperitoneum - A surgical challenge: A case report. Int J Surg Case Rep 2020;77:486-9. [PMID: 33395831 DOI: 10.1016/j.ijscr.2020.11.051] [Reference Citation Analysis]
24 Muratori F, Frenos F, Bettini L, Matera D, Mondanelli N, Scorianz M, Cuomo P, Scoccianti G, Beltrami G, Greto D, Livi L, Baldi G, Roselli G, Capanna R, Campanacci DA. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution. J Orthop Sci 2018;23:1038-44. [PMID: 30007495 DOI: 10.1016/j.jos.2018.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
25 Kirchberg J, Weitz J. [Intra-abdominal and retroperitoneal sarcomas]. Chirurg 2016;87:255-66; quiz 267. [PMID: 26920140 DOI: 10.1007/s00104-016-0156-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Nizri E, Fiore M, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Morosi C, Stacchiotti S, Casali PG, Gronchi A. Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysis. J Surg Oncol 2019;119:318-23. [PMID: 30554403 DOI: 10.1002/jso.25337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Callegaro D, Miceli R, Mariani L, Raut CP, Gronchi A. Soft tissue sarcoma nomograms and their incorporation into practice. Cancer. 2017;123:2802-2820. [PMID: 28493287 DOI: 10.1002/cncr.30721] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 10.6] [Reference Citation Analysis]
28 Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma. Journal of the American College of Surgeons 2017;224:876-83. [DOI: 10.1016/j.jamcollsurg.2017.01.044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
29 Molina G, Hull MA, Chen YL, DeLaney TF, De Amorim Bernstein K, Choy E, Cote G, Harmon DC, Mullen JT, Haynes AB. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma. J Surg Oncol 2016;114:814-20. [PMID: 27634478 DOI: 10.1002/jso.24427] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
30 Tsuchiya R, Yoshimatsu Y, Noguchi R, Sei A, Takeshita F, Sugaya J, Fukushima S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-DDLPS1-C1: a novel patient-derived cell line of dedifferentiated liposarcoma. Hum Cell 2021;34:260-70. [PMID: 32949334 DOI: 10.1007/s13577-020-00436-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Tirumani SH, Tirumani H, Jagannathan JP, Shinagare AB, Hornick JL, Ramaiya NH, Wagner AJ. Metastasis in dedifferentiated liposarcoma: Predictors and outcome in 148 patients. Eur J Surg Oncol 2015;41:899-904. [PMID: 25659772 DOI: 10.1016/j.ejso.2015.01.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
32 Willis F, Musa J, Schimmack S, Hinz U, Mechtersheimer G, Uhl M, Schmidt T, Fröhling S, Büchler MW, Schneider M. Outcome after surgical resection of multiple recurrent retroperitoneal soft tissue sarcoma. Eur J Surg Oncol 2021;47:2189-200. [PMID: 33980415 DOI: 10.1016/j.ejso.2021.04.040] [Reference Citation Analysis]
33 Callegaro D, Miceli R, Gladdy RA. Prognostic models for RPS patients-Attempting to predict patient outcomes. J Surg Oncol 2018;117:69-78. [DOI: 10.1002/jso.24903] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
34 Peacock O, Patel S, Simpson JA, Walter CJ, Humes DJ. A systematic review of population-based studies examining outcomes in primary retroperitoneal sarcoma surgery. Surg Oncol 2019;29:53-63. [PMID: 31196494 DOI: 10.1016/j.suronc.2019.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
35 Sandrucci S, Ponzetti A, Gianotti C, Mussa B, Lista P, Grignani G, Mistrangelo M, Bertetto O, Di Cuonzo D, Ciccone G. Different quality of treatment in retroperitoneal sarcomas (RPS) according to hospital-case volume and surgeon-case volume: a retrospective regional analysis in Italy. Clin Sarcoma Res 2018;8:3. [PMID: 29507712 DOI: 10.1186/s13569-018-0091-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
36 Hamilton TD, Cannell AJ, Kim M, Catton CN, Blackstein ME, Dickson BC, Gladdy RA, Swallow CJ. Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment. Ann Surg Oncol 2017;24:211-8. [DOI: 10.1245/s10434-016-5523-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
37 Zheng QG, Sun ZH, Chen JJ, Li JC, Huang XJ. Paratesticular liposarcoma: Two case reports. World J Clin Cases 2021; 9(2): 457-462 [PMID: 33521115 DOI: 10.12998/wjcc.v9.i2.457] [Reference Citation Analysis]
38 Carboni F, Valle M, Federici O, Covello R, Garofalo A. Giant Primary Retroperitoneal Dedifferentiated Liposarcoma. J Gastrointest Surg 2019;23:1521-3. [DOI: 10.1007/s11605-018-3851-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
39 Gahvari Z, Parkes A. Dedifferentiated Liposarcoma: Systemic Therapy Options. Curr Treat Options Oncol 2020;21:15. [PMID: 32026050 DOI: 10.1007/s11864-020-0705-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
40 Issels R, Lindner LH. Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questions. Curr Opin Oncol 2016;28:447-52. [PMID: 27455134 DOI: 10.1097/CCO.0000000000000316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
41 Jiang C, Wang J, Wang Y, Zhao J, Zhu Y, Ma X, Zhou J, Yan X. Treatment Outcome Following Transarterial Chemoembolization in Advanced Bone and Soft Tissue Sarcomas. Cardiovasc Intervent Radiol 2016;39:1420-8. [DOI: 10.1007/s00270-016-1399-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
42 Callegaro D, Fiore M, Gronchi A. Personalizing surgical margins in retroperitoneal sarcomas. Expert Rev Anticancer Ther 2015;15:553-67. [PMID: 25797538 DOI: 10.1586/14737140.2015.1028375] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
43 Baheti AD, Jagannathan JP, O'Neill A, Tirumani H, Tirumani SH. Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists. Korean J Radiol 2017;18:94-106. [PMID: 28096721 DOI: 10.3348/kjr.2017.18.1.94] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
44 Jagannathan JP, Tirumani SH, Ramaiya NH. Imaging in Soft Tissue Sarcomas: Current Updates. Surg Oncol Clin N Am 2016;25:645-75. [PMID: 27591491 DOI: 10.1016/j.soc.2016.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
45 Siew CCH, Apte SS, Baia M, Gyorki DE, Ford S, van Houdt WJ. Retroperitoneal and Mesenteric Liposarcomas. Surg Oncol Clin N Am 2022;31:399-417. [PMID: 35715141 DOI: 10.1016/j.soc.2022.03.005] [Reference Citation Analysis]
46 Dantey K, Schoedel K, Yergiyev O, Bartlett D, Rao UN. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas. Human Pathology 2017;66:86-92. [DOI: 10.1016/j.humpath.2017.02.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
47 Carvalho SD, Pissaloux D, Crombé A, Coindre JM, Le Loarer F. Pleomorphic Sarcomas: The State of the Art. Surg Pathol Clin 2019;12:63-105. [PMID: 30709449 DOI: 10.1016/j.path.2018.10.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
48 Angele MK, Albertsmeier M, Prix NJ, Hohenberger P, Abdel-Rahman S, Dieterle N, Schmidt M, Mansmann U, Bruns CJ, Issels RD, Jauch KW, Lindner LH. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 2014;260:749-54; discussion 754-6. [PMID: 25379845 DOI: 10.1097/SLA.0000000000000978] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 6.1] [Reference Citation Analysis]
49 Ochi T, Mizobuchi T, Hiroshima K, Nagato K, Itoh T, Kuroda F, Yamazaki K, Kato I, Hisaoka M, Nakatani Y. A successful trimodality therapy for difficult-to-diagnose primary mediastinal dedifferentiated liposarcoma, which originated from the perihilar fat and invaded the right lungs. Gen Thorac Cardiovasc Surg 2021. [PMID: 34784002 DOI: 10.1007/s11748-021-01735-w] [Reference Citation Analysis]
50 Luo P, Cai W, Yang L, Wu Z, Chen Y, Zhang R, Yan W, Shi Y, Wang C. Retroperitoneal dedifferentiated liposarcoma: Analysis of 61 cases from a large institution. J Cancer 2018;9:3831-8. [PMID: 30410585 DOI: 10.7150/jca.25715] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
51 Ben Salha I, Zaidi S, Noujaim J, Miah AB, Fisher C, Jones RL, Thway K. Rare Aggressive Behavior of MDM2-Amplified Retroperitoneal Dedifferentiated Liposarcoma, with Brain, Lung and Subcutaneous Metastases. Rare Tumors 2016;8:6282. [PMID: 27746879 DOI: 10.4081/rt.2016.6282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
52 Tirumani SH, Wagner AJ, Tirumani H, Shinagare AB, Jagannathan JP, Hornick JL, George S, Ramaiya NH. Is the nonlipomatous component of dedifferentiated liposarcoma always soft tissue on CT? Analysis of CT densities and correlation with rate of growth in 60 patients. Abdom Imaging 2015;40:1248-54. [DOI: 10.1007/s00261-014-0267-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
53 Yan Y, Xia S, Teng D, Hu S, Li S, Wang Y, Du X, Li R. Resection outcomes for primary and local recurrent retroperitoneal liposarcoma patients. Ann Transl Med 2020;8:1450. [PMID: 33313195 DOI: 10.21037/atm-20-6316] [Reference Citation Analysis]
54 Lou J, Moten AS, Reddy SS, Howell KJ, Movva S, von Mehren M, Farma JM. Retroperitoneal Sarcomas: Does Laterality Matter? J Surg Res 2019;244:34-41. [PMID: 31279261 DOI: 10.1016/j.jss.2019.05.016] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Tucci JJ, Dashti NK, Cates JMM. A Proposed Staging System for Improved Prognostication of MDM2-amplified Liposarcoma. Am J Surg Pathol 2021;45:101-7. [PMID: 32796171 DOI: 10.1097/PAS.0000000000001554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Zhao R, Yu X, Feng Y, Wang J, Mao Y, Yin W, Zhang Z, Guo X, Ma S. The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma. Jpn J Clin Oncol 2018;48:799-805. [PMID: 30060202 DOI: 10.1093/jjco/hyy105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Gyorki DE, Choong PFM, Slavin J, Henderson MA. Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcoma. ANZ J Surg. 2018;88:274-277. [PMID: 28768365 DOI: 10.1111/ans.14125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
58 Horowitz J, Singhal M, Marrero D, Bashjawish F, Leto D, Winters M, Jeberaeel J. A Multi-Modality Treatment of Retroperitoneal De-Differentiated Liposarcoma. Am J Case Rep 2020;21:e919245. [PMID: 32115569 DOI: 10.12659/AJCR.919245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Pollock RE, Payne JE, Rogers AD, Smith SM, Iwenofu OH, Valerio IL, Zomerlei TA, Howard JH, Dornbos D 3rd, Galgano MA, Goulart C, Mendel E, Miller ED, Xu-Welliver M, Martin DD, Haglund KE, Bupathi M, Chen JL, Yeager ND. Multidisciplinary sarcoma care. Curr Probl Surg 2018;55:517-80. [PMID: 30526918 DOI: 10.1067/j.cpsurg.2018.10.006] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Cho CW, Lee KW, Park H, Kim HJ, Park JB, Choi YL, Yu JI, Lee SJ, Choi DI, Kim SJ. Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma. Asia Pac J Clin Oncol 2018;14:e465-71. [PMID: 29044883 DOI: 10.1111/ajco.12769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Bhosale P, Wang J, Varma D, Jensen C, Patnana M, Wei W, Chauhan A, Feig B, Patel S, Somaiah N, Sagebiel T. Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma? J Comput Assist Tomogr 2016;40:872-9. [PMID: 27454788 DOI: 10.1097/RCT.0000000000000462] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
62 Kallen ME, Hornick JL. The 2020 WHO Classification: What's New in Soft Tissue Tumor Pathology? Am J Surg Pathol 2021;45:e1-e23. [PMID: 32796172 DOI: 10.1097/PAS.0000000000001552] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 25.0] [Reference Citation Analysis]
63 Gronchi A, Collini P, Miceli R, Valeri B, Renne SL, Dagrada G, Fiore M, Sanfilippo R, Barisella M, Colombo C, Morosi C, Stacchiotti S, Casali PG, Dei Tos AP, Pilotti S. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma. Am J Surg Pathol. 2015;39:383-393. [PMID: 25581729 DOI: 10.1097/pas.0000000000000366] [Cited by in Crossref: 57] [Cited by in F6Publishing: 23] [Article Influence: 8.1] [Reference Citation Analysis]
64 Albertsmeier M, Werner J, Lindner LH, Belka C, Issels RD, Angele MK. [Operative therapy of abdominal and retroperitoneal sarcoma]. Chirurg 2014;85:391-7. [PMID: 24736805 DOI: 10.1007/s00104-013-2688-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]